- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06330649
The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Energy drink consumption has gained a lot in popularity and represents one of the most rapidly growing segments of the beverage industry. While regularly discussed in media outlets etc. the cardiovascular effects are not well described or well known. For example, the impacts on various cardiovascular parameters range from improved, decreased, to not impacted at all depending on the source. This can be due to a number of reasons including, study protocol design, study population tested, energy drink product used, volume consumed, etc. Accordingly, this study aims to investigate the impact of acute consumption of a standard commercially available can of energy drink beverage on the following parameters.
- Arterial blood pressure
- Heart rate
- Energy metabolism (oxygen consumption and carbon dioxide production
It is hypothesized that consumption of a 12 oz energy drink will result in modest elevations in arterial blood pressure, heart rate, and energy metabolism relative to when consuming of an equal volume of water.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Robert M Brothers, PhD
- Phone Number: 817-272-3288
- Email: matthew.brothers@uta.edu
Study Contact Backup
- Name: Alison Mancera, BS
- Phone Number: 8172723288
- Email: alison.mancera@mavs.uta.edu
Study Locations
-
-
Texas
-
Arlington, Texas, United States, 76019
- Recruiting
- UT Arlington - Science and Engineering Innovation and Research Building
-
Contact:
- Robert M Brothers, PhD
- Phone Number: 817-272-3288
- Email: matthew.brothers@uta.edu
-
Contact:
- Alison Mancera, BS
- Phone Number: 8172723288
- Email: alison.mancera@mavs.uta.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Between ages 18-30
- Must be free of reported cardiovascular, respiratory, and metabolic diseases.
- Must be caffeine naïve
- Must be fasted
Exclusion Criteria:
- Food allergies
- pregnant women
- Breast feeding women
- Individuals with cardiac, cardiovascular, respiratory, metabolic, and/or neurological disorders
- taking any prescription vasoactive medications
- allergies to spandex/lycra
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Energy Drink
A commercially available caffeine drink containing 200 mgs of caffeine.
|
This is a commercially available energy drink
|
Placebo Comparator: Water
This will be 12 fl oz of commercially available water .
|
This is a commercially available bottled water
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peripheral blood pressure in millimeters of mercury
Time Frame: baseline & 30, 60, 90, 120 min following beverage consumption
|
blood pressure will be measured on the upper arm using standard procedures that are done in a doctors office.
|
baseline & 30, 60, 90, 120 min following beverage consumption
|
Oxygen consumption milliliters per kilogram of body weight per minute
Time Frame: baseline & 30, 60, 90, 120 min following beverage consumption
|
This will be assessed using a metabolic cart to measure the amount of oxygen that is consumed by the body.
|
baseline & 30, 60, 90, 120 min following beverage consumption
|
Heart rate in beats per minute
Time Frame: baseline & 30, 60, 90, 120 min following beverage consumption
|
Heart will be measured using an electrocardiogram procedures that are done in a doctors office.
|
baseline & 30, 60, 90, 120 min following beverage consumption
|
Collaborators and Investigators
Investigators
- Principal Investigator: Robert M Brothers, PhD, University of Texas at Arlington
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-0095
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
Clinical Trials on Energy Drink
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Mayo ClinicCompletedCardiovascular System | Hemodynamics | Energy DrinksUnited States
-
University of the PacificCompletedBlood Pressure | Electrical Alternation of HeartUnited States
-
Université de MontréalUnknown
-
Karolinska InstitutetRegion Stockholm; Research department, Ersta HospitalTerminated
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
David Grant U.S. Air Force Medical CenterCompletedQTc IntervalUnited States
-
Utrecht Institute for Pharmaceutical SciencesRed Bull GmbHCompleted